CBClive Brown

Clive Brown

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Clive Brown has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Case Series of Reports to US Port Health Stations of Travelers With Suspected or Confirmed Cholera, 2005-2024

    by Taylor H. Nguyen, Karla Bagley, Erin Rothney, Francisco Alvarado-Ramy, Clive Brown, Sundari Mase, Christine C. Lee, Alida M. Gertz

    From 2005 to 2024, the Centers for Disease Control and Prevention’s port health stations (PHSs) received 37 reports of travelers with suspected or confirmed cholera. Most reports (29/37, 78%) occurred before 2012, with the majority linked to the 2010 Haiti outbreak. The median age of travelers was 34 years (interquartile range: 21-59 years), and nearly all (35/37, 95%) arrived by air. Seventeen (46%) cases were laboratory-confirmed as toxigenic Vibrio cholerae O1, serotype Ogawa; 16 (94%) patients with confirmed cholera were hospitalized. No deaths were reported. Following the publication in 2011 of notification criteria for communicable diseases in travelers, health department notifications to PHSs of cholera cases declined. Continued coordination with public health partners is important to ensure timely evaluation and follow-up of travelers with suspected cholera. Clinicians should obtain travel histories and consider cholera in recent travelers with severe watery diarrhea who have been in outbreak or endemic areas.

  • A Review of Malaria, Diphtheria, and Botulism Medication Distributions by CDC Port Health Stations From May 2006 to February 2024

    by Lily Rubin, Jennifer Fowler, Srikar Ranga, Máire Kirley, Joshua Tchan, Maria Pacheco, Leigh Ellyn Preston, Michelle A. Waltenburg, Olubunmi Akinkugbe, Michael H. Kinzer, et al.

    Objectives: The Centers for Disease Control and Prevention (CDC) maintains a formulary of biologic agents and drugs not available commercially in the United States. For a subset of these (botulism and diphtheria antitoxins and, until 2022, intravenous artesunate for severe malaria), distribution is coordinated through CDC port health stations (PHS), located mainly at major US international airports. CDC aims for these drugs to reach their destinations within 8 hours of release authorization. We analyzed CDC records to identify areas for efficiency improvement. Design: We queried records detailing drug distributions from PHS that occurred May 2006 to February 2024, including timing of release authorization and delivery, geographic origins and destinations, mode of transportation, and patient characteristics and outcomes. We conducted descriptive and multivariate analyses to identify variables that may have delayed delivery. Setting: CDC port health stations. Main Outcome Measures: Time from release authorization to drug delivery. Results: CDC PHS distributed 2912 drug shipments between May 2006 and February 2024 via 17 distribution sites to 54 jurisdictions across the US and 3 countries. Of 850 shipments for which data were available (those occurring December 2019 or later), 83% (n = 702/850) occurred within 8 hours of authorization. Commercial air transport (compared to other types of transport) (aOR: 11.43, 95% confidence interval [CI]: 6.94-18.81, P < .001) and release authorization time (outside of vs within routine work hours) (aOR: 5.10, 95% CI: 3.31-7.86, P < .001) were significantly associated with delays. Conclusions: CDC PHS facilitated emergency distributions of life-saving drugs for botulism, diphtheria, and severe malaria to locations throughout the US mostly within 8 hours of authorization. Staffing, distribution locations, and expanded options for ground transportation are important considerations that may minimize delays.

  • A Review of Reports to CDC of Travelers Who Flew While Infectious With Pertussis From April 2013 to February 2024

    by Kristen Pringle, Robert Mason Clark, Jennifer J Fowler, Shannon L Gearhart, Leslie Hausman, Paisley Rearden, Grayson K Walker, Michael Kinzer, Leigh Ellyn Preston, Clive Brown, et al.

    Context: Pertussis is endemic worldwide, and exposure can occur anywhere, including commercial aircraft. Travelers exposed to an infectious person with pertussis may receive post-exposure prophylaxis (PEP) for up to 21 days after exposure to decrease risk of infection. This is accomplished through the identification of infectious travelers and their aircraft contacts (a process called aircraft contact investigation [Air CIs]). Objective: Describe travelers reported to the US Centers for Disease Control and Prevention (CDC) who flew while infectious with pertussis and outcomes of associated Air CIs. Design: CDC’s Port Health Activity Reporting System (PHARS) was queried to identify reports of travelers who flew with pertussis from April 12, 2013, to February 28, 2024. Participants: Index cases (passengers or crew members) with pertussis who traveled on commercial aircraft and their exposed passenger contacts. Main Outcome Measure(s): Traveler demographics, flight characteristics, outcome data from Air CIs. Results: Three hundred and eight individuals who recently traveled on commercial aircraft with pertussis were identified. Of the passengers determined to be infectious on the flights, Air CIs were initiated for 102/270 (38%) travelers who flew on 163/500 (33%) flights. Among the 337/500 (67%) flights for which Air CI was not initiated, the most common reason was that the index case was seated adjacent to only household members (142/337, 42%). For flights in which Air CIs were initiated, 234 contacts were identified, and one secondary case in a non-household passenger contact was reported. The average time from when contacts were exposed during the flight to when a health department reported the index case to CDC was 11.6 days (median 10.3 days, range: 0-39 days). Conclusions: Timely reporting of pertussis cases after air travel may decrease transmission risk to passenger contacts and prevent severe illness.


  • Human exposures to Brucella canis from a pregnant dog during an international flight: Public health risks, diagnostic challenges and future considerations

    by Cara Williams, Samantha Swisher, Nicholas Miller, Toby Pinn‐Woodcock, Connie Austin, Shih‐Hsuan Hsiao, Angela M. Arenas‐Gamboa, Rebekah Tiller, Tyler Thacker, Sara Taetzsch, et al.

    Aims: This report documents the exposure of passengers and crew of a commercial international flight to the zoonotic pathogen Brucella canis after an infected dog aborted in the passenger cabin of the aircraft. This case demonstrates the challenges associated with brucellosis screening and the risks that airline personnel, airport employees and travellers face when animals with unrecognized zoonotic infections are transported. Methods/Results: The public health investigation of this case was conducted by the Centers for Disease Control, the Illinois Department of Health and the Illinois Department of Agriculture, in collaboration with a local veterinary clinic and several academic and federal diagnostic laboratories. It included an extensive diagnostic evaluation of the dam and aborted foetuses to confirm a diagnosis of canine brucellosis. Passengers, airline personnel and staff from the veterinary clinic where the dogs were treated underwent risk assessments, and clinic staff also received detailed guidance regarding infection prevention practices. Conclusions: Animal shelters and breeding programs are recommended to screen dogs routinely for brucellosis, but it is not unusual for domestic or imported animals to have unknown health histories, including the dog's brucellosis status, at the time of purchase, adoption, or re‐homing. Testing recommendations and requirements vary by state, making it challenging for state public health and animal health agencies to monitor and respond appropriately. This case highlights the importance of Brucella spp. screening in sexually intact dogs prior to breeding, purchase, or domestic or international transportation of the dogs. The transportation of pregnant dogs may present a previously unrecognized public health threat in addition to contributing to unnecessary stress and health risks for pregnant animals.


  • Open Access

    Demographic and travel characteristics and self‐reported predeparture SARS‐CoV‐2 testing behavior in air passengers entering the United States from foreign destinations from July to September 2021

    by Anthony Panasci, Shannon Gearhart, Anna Shaum, Arthur J. Simental, Colby Mitchell, Dionne Mitcham, Gilandria Williams, Nadim Shake, Clive Brown, Alida M. Gertz

    Introduction: From January 2021 to June 2022, the United States Centers for Disease Control and Prevention required predeparture SARS‐CoV‐2 testing for all air passengers arriving into the United States from a foreign country.Methods: Using data collected during a surveillance project, we described predeparture testing behavior among a convenience sample of international air passengers entering the United States from July to September 2021 at six US ports of entry. We analyzed pairwise relationships between self‐reported test type, test timing, demographic and travel characteristics, and COVID‐19 vaccination status using chi‐square and Fisher's exact tests.Results: Participants were more likely to get a NAAT versus antigen test if they identified as non‐Hispanic Asian or Pacific Islander (68.2%, n = 173), non‐Hispanic Black (62.6%, n = 147), or if they preferred not to report race and ethnicity (60.8%, n = 209) when compared to those who identified as non‐Hispanic White (47.1%, n = 1086, all p < 0.05). Those who identified as Hispanic or Latino (n = 671) were less likely to get a NAAT than the non‐Hispanic White group (39.5% vs. 47.1%, p < 0.05). Participants arriving in the US from the Americas were less likely to get a NAAT (38.5%, n = 871) compared to those arriving from Europe (45.5%, n = 1165, p < 0.05). Participants who reported receiving their predeparture test 2 days or 3 or more days before departure were more likely to report receiving a NAAT (52.2%, n = 879, and 60.2%, n = 410, respectively) than those who reported testing within 1 day (41.4%, n = 1040, all p < 0.001) of departure.Discussion: Test type was significantly associated with race and ethnicity, departure region, and test timing. Differences likely reflected regional disparities in the availability of tests at the time of the activity. Discrepancies in predeparture test timing and type worldwide may have consequences for the effectiveness and equity of travel requirements in future pandemics.